Glioma
U.S. PATIENTS:713.790.3333
Find a Specialist Near You
The glioma experts at Houston Methodist are proven leaders in precise, personalized brain tumor diagnosis, treatment, and research. We provide patients innovative, personalized care plans with treatment options not available elsewhere in Texas.
The Glial Tumor Treatment Program at Houston Methodist offers highly effective treatments for patients with common to complex tumor cases.
Glioma patients come to us from all over Texas and the U.S., seeking access to our advanced technology and customized treatment plans. Our research-backed expertise encompasses the entirety of the patient’s journey, from diagnosis to support, dramatically improving lives and ensuring the best outcomes.
Houston Methodist is also dedicated to furthering knowledge toward a cure for gliomas. Our passionate team of experts at the Kenneth R. Peak Center for Brain and Pituitary Tumor Treatment and Research is pioneering the future through ongoing research projects and exclusive clinical trial and treatment options.
Pioneering Glioma Treatment in Houston and the U.S.
Gliomas — tumors that start in the brain or spine — make up 33% of all brain tumors. If you or a loved one is seeking a diagnosis or treatment, our world-class team will provide hope and proven solutions during your journey.
- Targeted diagnosis – We analyze the genes in each tumor to determine the precise tumor make-up and behavior. We then test against every known U.S. chemotherapeutic agent. Our diagnostic innovation leads to the best possible outcomes.
- Personalized, comprehensive treatment – We offer intensive and aggressive treatment plans — including surgery and DNA and gene analyses — delivered by a diversely skilled team of compassionate experts.
- Clinical trials and research – Houston Methodist is a leader in innovative research, pioneering treatments with fewer side effects and one-of-a-kind gene therapy, leading to healthier and longer lives for our patients.
Supporting You Throughout Your Journey
Find Clinical Trials
Patient Success